CARNITEN SOLUTION FOR INTERNAL USE 1000MG/10ML
CARNITEN SOLUTION FOR INTERNAL USE 1000MG/10ML - 10 pcs
Security policy (edit with Customer reassurance module)
Delivery policy (edit with Customer reassurance module)
Return policy (edit with Customer reassurance module)
Mechanism of action
Anabolic, antihypoxic, regenerating, antithyroid.
It is easily absorbed from the intestines, penetrates into all tissues, the greatest concentrations are created in the skeletal muscles and myocardium. C_max is reached after 3 hours and remains at the therapeutic level for up to 9 hours. Excreted by the kidneys unchanged (more than 80% for 24 hours).
Indications and usage
Congenital primary and secondary Carnitine deficiency; acquired secondary carnitine deficiency with total parenteral nutrition, chronic hemodialysis, valproic acid intake, intense physical exertion; prematurity, lag in growth and body mass, perinatal CNS pathology in newborns and premature infants; angina pectoris, acute myocardial infarction, cardiogenic shock, post-infarction conditions, diseases of the peripheral arteries.
In / in slowly. Secondary deficiency in hemodialysis: 2 g once (after the procedure); acute myocardial infarction: 100–200 mg / kg / day in 4 doses or continuous administration for the first 48 hours, followed by a 2-fold reduction in the dose; cardiogenic shock: in / in before the patient leaves the shock. Inside, a single dose from the vial is diluted with a glass of water.Primary and secondary deficiency in genetic diseases: children under 2 years old - 150 mg / kg / day, 2-6 years old - 100 mg / kg / day, 6-12 years old - 75 mg / kg / day, from 12 years old and adults 2-4 g / kg / day; secondary deficiency in hemodialysis: 2-4 g per day; angina and post-infarction conditions: 2-6 g per day.
Gastrointestinal disorders (after oral administration), mild myasthenic symptoms (in patients with uremia).
Hypersensitivity to the drug.
Pregnancy and breastfeeding
With no restrictions.